Experts explore the underlying biology of cancer and potential therapeutic strategies
Cancer's global impact is severe, affecting millions worldwide and driving cancer research to the forefront of biomedical science.
Sep 12, 2023
0
6
Cancer's global impact is severe, affecting millions worldwide and driving cancer research to the forefront of biomedical science.
Sep 12, 2023
0
6
A unified and concentrated lung cancer advocacy program in the United States resulted in a 25% increase in funding to a U.S.-based lung cancer research program, according to a presentation given at the International Association ...
Sep 12, 2023
0
0
A new radioactive medicine that seeks out tumor cells to deliver a targeted dose of radiation greatly improves quality of life for patients with advanced prostate cancer, a phase III study finds.
Sep 11, 2023
0
9
There's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990–2019), finds research published in the open access journal BMJ Oncology.
Sep 5, 2023
0
81
Prostate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with ...
Aug 30, 2023
0
28
Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to side-effects of treatment.
Aug 30, 2023
0
4
While new research suggests cancer screenings are not extending lives for the most part, the study's authors stressed that there are still good reasons why people should continue with screenings.
Aug 29, 2023
0
16
Actinium-targeted alpha radiotherapy is a promising approach for treating metastatic cancers, including prostate cancer. This approach requires doctors to obtain images of the radiotherapy agent as it moves to tumors, a process ...
Aug 28, 2023
0
1
A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, ...
Aug 28, 2023
0
46
The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 participants found to have ...
Aug 21, 2023
0
15